WEST Perth-based medical device manufacturer, Eastland Medical Systems, has secured a contract, through its South African subsidiary, to produce anti-malaria medication for the African continent. The agreement was signed between Eastland’s 65 per cent-owned subsidiary Eastland Medical Systems South Africa (EMSSA) and Star Medical (Botswana), with manufacturing expected to commence in mid 2008 following regulatory approvals on the anti-malaria treatment and the establishment of manufacturing facilities. A clinical validation study of the treatment, conducted in Nigeria, found a 100 per cent effective success rate in all patients tested. Eastland Medical Systems chief executive officer Dermot Patterson said negotiations were currently under way to acquire a new manufacturing plant. The manufacturing agreement follows a distribution agreement signed between EMSSA and Star in December, which granted EMSSA the distribution rights for its anti-malaria treatment to the 47 countries within sub-Saharan Africa. Eastland also announced that it had terminated an agreement, established in August 2005, to purchase an 80 per cent equity in South African medical device manufacturer, Elite Surgical Supplies, following the new agreement.
News
>
20/02/2007 - 22:00
Eastland in African deal
20/02/2007 - 22:00
Related Data & Insights
-
Arovella TherapeuticsClosing price for the last 90 trading daysPowered by Morningstar ®
-
Rank Company Revenue 974th Arovella Therapeutics $1.5m 1173rd Real Energy Corporation $11k 1176th Peako $8k 1183rd Bentley Capital $2k 1186th Orion Metals $1k 1330 listed non wa companies ranked by revenue.
Powered by Morningstar ®
Data & Insights
Mentioned Organisations
Related Articles
13 Mar 2023
Board Moves March 13, 2023
26 Oct 2022
Arovella to shut Perth R&D facility
01 Jul 2022
Board Moves July 1, 2022
07 Jun 2022
Board Moves June 7, 2022
Subscribe today for award-winning, unbiased and trusted journalism
Subscription OptionsX